Ruby John Anto

4.7k total citations · 1 hit paper
80 papers, 3.8k citations indexed

About

Ruby John Anto is a scholar working on Molecular Biology, Molecular Medicine and Organic Chemistry. According to data from OpenAlex, Ruby John Anto has authored 80 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 23 papers in Molecular Medicine and 20 papers in Organic Chemistry. Recurrent topics in Ruby John Anto's work include Curcumin's Biomedical Applications (22 papers), Synthesis and biological activity (11 papers) and Natural product bioactivities and synthesis (11 papers). Ruby John Anto is often cited by papers focused on Curcumin's Biomedical Applications (22 papers), Synthesis and biological activity (11 papers) and Natural product bioactivities and synthesis (11 papers). Ruby John Anto collaborates with scholars based in India, United States and Israel. Ruby John Anto's co-authors include Devarajan Karunagaran, Smitha V. Bava, Arun Kumar T. Thulasidasan, Ramadasan Kuttan, Vinod Balachandran, Gopal Srinivas, Tessy Thomas Maliekal, Girija Kuttan, Lekshmi R. Nath and S. Asha Nair and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ruby John Anto

79 papers receiving 3.7k citations

Hit Papers

The role of AMPK in cance... 2023 2026 2024 2023 25 50 75 100

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ruby John Anto 1.9k 991 633 485 436 80 3.8k
Vivek R. Yadav 1.7k 0.9× 446 0.5× 410 0.6× 311 0.6× 394 0.9× 60 3.5k
Imtiaz A. Siddiqui 2.6k 1.3× 628 0.6× 342 0.5× 455 0.9× 538 1.2× 88 6.2k
Devivasha Bordoloi 1.9k 1.0× 859 0.9× 282 0.4× 310 0.6× 410 0.9× 50 3.7k
Miguel López‐Lázaro 2.8k 1.5× 388 0.4× 669 1.1× 857 1.8× 668 1.5× 98 5.8k
Pornngarm Limtrakul 2.3k 1.2× 1.5k 1.5× 356 0.6× 438 0.9× 324 0.7× 120 4.7k
Santosh K. Sandur 3.1k 1.6× 1.4k 1.4× 564 0.9× 405 0.8× 678 1.6× 88 5.9k
Haruyo Ichikawa 2.6k 1.3× 1.6k 1.6× 404 0.6× 525 1.1× 563 1.3× 36 5.5k
Kishore Banik 2.0k 1.0× 488 0.5× 244 0.4× 353 0.7× 522 1.2× 46 3.7k
Katrin Sak 2.8k 1.4× 327 0.3× 454 0.7× 729 1.5× 608 1.4× 125 5.9k
S.M. Hadi 1.8k 0.9× 416 0.4× 720 1.1× 514 1.1× 281 0.6× 86 4.2k

Countries citing papers authored by Ruby John Anto

Since Specialization
Citations

This map shows the geographic impact of Ruby John Anto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby John Anto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby John Anto more than expected).

Fields of papers citing papers by Ruby John Anto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby John Anto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby John Anto. The network helps show where Ruby John Anto may publish in the future.

Co-authorship network of co-authors of Ruby John Anto

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby John Anto. A scholar is included among the top collaborators of Ruby John Anto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby John Anto. Ruby John Anto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Keerthana, Chenicheri K., et al.. (2024). Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules. SHILAP Revista de lepidopterología. 2(6). 744–784. 3 indexed citations
3.
Latha, M.S., et al.. (2024). A promising study on cytotoxicity and in vitro anti-inflammatory activity of Heracleum candolleanum (Wight et. Arn.) gamble. Journal of Pharmacognosy and Phytochemistry. 13(4). 59–63. 1 indexed citations
4.
Keerthana, Chenicheri K., et al.. (2023). Putative role of uttronin (degalactotigonin) in cytotoxicity of uttroside B in HepG2 cells. Tetrahedron Letters. 127. 154668–154668. 1 indexed citations
5.
Lankalapalli, Ravi S., et al.. (2023). A potent bioactive fraction against colon cancer from Plectranthus vettiveroides. SHILAP Revista de lepidopterología. 4(2). 227–239. 2 indexed citations
6.
Keerthana, Chenicheri K., et al.. (2023). The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Frontiers in Immunology. 14. 1114582–1114582. 111 indexed citations breakdown →
7.
Liju, Vijayasteltar Belsamma, Chenicheri K. Keerthana, Sankar Sundaram, et al.. (2022). Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential. Frontiers in Oncology. 12. 903832–903832. 8 indexed citations
8.
Nair, Bhagyalakshmi, Ruby John Anto, M. Sabitha, & Lekshmi R. Nath. (2020). Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach. Advanced Pharmaceutical Bulletin. 10(3). 472–476. 31 indexed citations
9.
Schouteden, Sarah, Vinod Vijayakurup, Ruby John Anto, et al.. (2020). The Periostin/Integrin-αv Axis Regulates the Size of Hematopoietic Stem Cell Pool in the Fetal Liver. Stem Cell Reports. 15(2). 340–357. 15 indexed citations
10.
Vijayakurup, Vinod, Archana P. Retnakumari, Jayesh Antony, et al.. (2019). Chitosan Encapsulation Enhances the Bioavailability and Tissue Retention of Curcumin and Improves its Efficacy in Preventing B[a]P-induced Lung Carcinogenesis. Cancer Prevention Research. 12(4). 225–236. 46 indexed citations
11.
Anto, Ruby John, et al.. (2019). Synthesis of Novel Benzamide- piperazine-sulfonamide Hybrids as Potential Anticancer Agents. Croatica Chemica Acta. 92(3). 393–402. 3 indexed citations
12.
Nath, Lekshmi R., Arun Kumar T. Thulasidasan, Vinod Vijayakurup, et al.. (2016). Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma. Scientific Reports. 6(1). 36318–36318. 37 indexed citations
13.
Bava, Smitha V., et al.. (2016). Cervical cancer: A comprehensive approach towards extermination. Annals of Medicine. 48(3). 149–161. 13 indexed citations
15.
Nath, Lekshmi R., et al.. (2014). Cytotoxicity studies of semi-synthetic derivatives of theveside derived from the aqueous extract of leaves of ‘suicide tree’Cerbera odollam. Natural Product Research. 28(18). 1507–1512. 4 indexed citations
18.
Maliekal, Tessy Thomas, Ruby John Anto, & Devarajan Karunagaran. (2004). Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-β. Journal of Biological Chemistry. 279(35). 36287–36292. 23 indexed citations
19.
Anto, Ruby John, et al.. (2003). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology. 485(1-3). 97–103. 183 indexed citations
20.
Anto, Ruby John, et al.. (1998). Anti‐inflammatory Activity of Natural and Synthetic Curcuminoids. Pharmacy and Pharmacology Communications. 4(2). 103–106. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026